Zobrazeno 1 - 10
of 14
pro vyhledávání: '"B J Srinivasa"'
Autor:
Lalkota, Bhanu Prakash1 bhanu.lalkota@gmail.com, B. J., Srinivasa2, Swamy, Mani V.3, Hazarika, Diganta1, B. M., Jeet1, K., Jyothi1, Ghosh, Mithua4, Sayeed, Suhail M.1, Nasiruddin, Mohammad4, Naik, Radheshyam1
Publikováno v:
Journal of Cancer Research & Therapeutics. Mar2023, Vol. 19 Issue 2, p208-213. 6p.
Autor:
Hai-Yan Tu, Jifeng Feng, Meiqi Shi, Jun Zhao, Yuyan Wang, Jianhua Chang, Jialei Wang, Ying Cheng, Jing Zhu, Eng-Huat Tan, Kai Li, Yiping Zhang, Victor Lee, Cheng-Ta Yang, Wu-Chou Su, David Chi-Leung Lam, B. J. Srinivasa, Senthil Rajappa, Ching-Liang Ho, Kwok Chi Lam, Yi Hu, Shailesh Arjun Bondarde, Xiaoqing Liu, Yahui Tian, Zhiyi Xue, Agnieszka Cseh, Dennis Chin-Lun Huang, Caicun Zhou, Yi-Long Wu
Publikováno v:
Targeted Oncology
Background Afatinib has been shown as a suitable option for the treatment of epidermal growth factor receptor mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC) in randomized controlled trials. However, patients treated in real-world clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dedb44b2bff7271eee630e4fb5dfed43
https://pubmed.ncbi.nlm.nih.gov/35020119
https://pubmed.ncbi.nlm.nih.gov/35020119
Autor:
Jun Zhao, B J Srinivasa, Hai-Yan Tu, Konstantin Laktionov, Filippo de Marinis, Tejaswini Jalikop, Jifeng Feng, Eng Huat Tan, Victor C. S. Lee, Cheng-Ta Yang, Dariusz M. Kowalski, Maya Gottfried, Yi-Long Wu, Artem Poltoratskiy, Dennis Chin-Lun Huang, Agnieszka Cseh, Keunchil Park, L. Clementi, Antonio Passaro
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundAfatinib is approved for first-line treatment of patients with epidermal growth factor receptor mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC). Here, we report findings from a combined analysis of three phase IIIb studies of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b75f20cf233bbd541527c8295d1f9fb
http://europepmc.org/articles/PMC8298067
http://europepmc.org/articles/PMC8298067
Autor:
Masayo Uji, Katerina Asonitou, Gerasimos Prodromitis, Dimitra Koutsouki, Yosra Alhindi, Rana Albarakati, Lujain Almatrafi, Ghaidaa Fatta, Batool Fatani, Upasana Dhar, Ramesh Nagarajappa, Dharmashree Satyarup, Marlin Jena, Abhilash Mohapatra, Abeer Alatawi, Meshaal Alanazi, Pankaj Kumar Mishra, Mohammed Nadeem, Anshul Khare, Vipin Singh, Jiten Shukla, Devendra Chaudhary, Mostafa Elnagger, Hussein A. Motaweh, Kareman Zard, Arbind Kumar Choudhary, Sundareswaran loganathan, Lubna Mohammed Thaher, Jafar Alasad, Mahmoud Maharmeh, Ibrahim Salami, Fidelia Chan Xue Ning, Siti Zamratol Mai-Sarah Mukari, Kartini Ahmad, Mihaela Vladu, Diana Clenciu, Ion Cristian Efrem, Mircea-Cătălin Forțofoiu, Anca Amzolini, Simona Tudorică Micu, Maria Moța, Maria Forțofoiu, E. V. Zakharova, E. S. Stolyarevich, Abdulmajeed Altoijry, Thamer Nouh, Ahmed Alburakan, Magdi Ibrahim, Talal A. Altuwaijri, Hala Mourad Demerdash, Gehan Sharara, Khaled Katri, Fabiano de Oliveira Araujo, Ana Paula Marchetti, Gisele Emilãine da Silva Reis, Paulo Augusto Pires Milani, Albano Luis Novaes Bueno, Yasmine Mendes Pupo, Vinu Sarathy, B. J. Srinivasa, Bhanu Lalkota, P. K. Kiran, Vishal Kulkarni, Samuel Luke Koramati, Radheshyam Naik, E. S. Anibor, Amit Lakhani, Ena Sharma, S. M. Bhatnagar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8284b22b983bc0283ee06e2eeeff0bc
https://doi.org/10.9734/bpi/ctmamr/v7
https://doi.org/10.9734/bpi/ctmamr/v7
Autor:
B. J. Srinivasa, Radheshyam Naik, Nithin Bayas, Vinu Sarathy, Sulav Sapkota, Bhanu Prakash Lalkota
Publikováno v:
Open Journal of Immunology. :107-111
Introduction: Immunotherapy is also called as biologic therapy or bio-therapy. Immunotherapy is quickly becoming an important component in the multipronged approaches being developed to treat certain forms of cancer. The goal of immunotherapy is to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aeb92fd61cf1719dc1fe919ccb90443
https://doi.org/10.4236/oji.2018.84007
https://doi.org/10.4236/oji.2018.84007
Publikováno v:
Indian Journal of Medical and Paediatric Oncology. 40:S133-S135
Drug-induced pancreatitis is reported as one of the less common causes of acute pancreatitis. Many drugs such as sulfonamides, estrogens, tetracyclines, valproic acid, antiretroviral drugs, some chemotherapy drugs such as azathioprine, and 6 MP are k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4507174e10bb727e97f5eb8ed49a0725
https://doi.org/10.4103/ijmpo.ijmpo_189_17
https://doi.org/10.4103/ijmpo.ijmpo_189_17
Autor:
B. J. Srinivasa, Sulav Sapkota, Shivakumar Swamy, Radheshyam Naik, Mona Priyadarshini, Bhanu Prakash Lalkota
Publikováno v:
Indian Journal of Case Reports. 5:225-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b4c602f912f8379a47bc3c2a9b00072
https://doi.org/10.32677/ijcr.2019.v05.i03.010
https://doi.org/10.32677/ijcr.2019.v05.i03.010
Autor:
G. S. Deepika, B. J. Srinivasa, Raghavendra M Rao, D. Tousif, Kiran Pk, Amritanshu Ram, Radheshyam Naik, Mohammad Nasiruddin, Sulav Sapkota, S. Patil, Girish Badarke, Vinu Sarathy, L. P. Bhanu, Vishal Kulkarni
Publikováno v:
Journal of Cancer Therapy. :838-844
Background: Lung cancer is the leading cause of cancer-related death worldwide with an estimated 1.6 million new cases diagnosed each year. According to standard guidelines in NSCLC, the effectiveness of combined chemotherapy regimen comprises of pem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c4d99e0f3c159463931e479f21aff25
https://doi.org/10.4236/jct.2017.89073
https://doi.org/10.4236/jct.2017.89073
Autor:
Radheshyam Naik, Shivakumar Swamy, Girish Badarke, B. J. Srinivasa, Mona Priyadarshini, R. Veena ., Sulav Sapkota
Publikováno v:
Indian Journal of Case Reports. 4:295-297
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fc7169c5b164190526328425aba5d28
https://doi.org/10.32677/ijcr.2018.v04.i04.014
https://doi.org/10.32677/ijcr.2018.v04.i04.014
Autor:
Mangesh Kamath, Mansi Khanderia, B. J. Srinivasa, Tousif Imdad Mubarak Devale, Radheshyam Naik
Publikováno v:
Indian J Surg Oncol
The intraperitoneal (IP) administration of antineoplastic agents has been proposed as a method to improve the efficacy of therapy of malignant disease principally confined to the peritoneal cavity especially in carcinoma-ovary. Our patient who had mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a739938ec99c9b14247e7d7de0ba411c
https://doi.org/10.1007/s13193-017-0628-3
https://doi.org/10.1007/s13193-017-0628-3